Currently available ventricular-assist devices: capabilities, limitations and future perspectives

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Devices

Background:

• End-stage heart failure management has advanced with Ventricular Assist Device (VAD) technology.
• Current VADs offer optimal therapies tailored to individual patient needs.
• VADs demonstrate extended durability, safety, and efficacy, improving patient quality of life.

Purpose of the Study:

• To review the current status, capabilities, and limitations of available VADs.
• To classify VADs based on support duration, pump alignment, and perfusion mode (pulsatile/nonpulsatile).
• To present future research and development directions for next-generation VADs.

Main Methods:

• Review of current Ventricular Assist Device (VAD) technology and patient management.
• Classification of VADs by support duration, pump alignment, and perfusion mode.
• Analysis of clinical outcomes and quality of life improvements.

Main Results:

• VADs are a viable alternative to heart transplantation for end-stage heart failure.
• Progressive generations of VAD technology show increasing clinical benefits.
• Current VADs offer diverse options to meet specific patient requirements.

Conclusions:

• Ventricular Assist Device (VAD) technology represents a significant advancement in treating heart failure.
• Ongoing development in VADs is crucial for enhancing clinical outcomes and patient well-being.
• Future VAD generations are expected to further improve treatment efficacy and patient quality of life.